Rigen Biotech

About:

Rigen Biotech focuses on the molecular diagnosis of thyroid tumors.

Website: http://www.rigen-bio.com/

Top Investors: BioTrack Capital, Boyuan Capital, Guotai Junan Innovation Investment, Yinshengtai Capital, Jinsheng Group

Description:

Rijing Biosciences has launched thyroid biopsy needles, multi-gene qPCR detection and NGS detection, Thyroscan® thyroid nodule benign and malignant classifier, and targeted surgery for thyroid cancer from preoperative sampling, diagnosis, to postoperative monitoring. Full-process series products such as post-recurrence monitoring provide a variety of solutions for the entire thyroid cancer diagnosis and treatment cycle.

Total Funding Amount:

100M CNY

Headquarters Location:

Minhang, Shanghai, China

Founded Date:

2017-01-01

Contact Email:

info(AT)rigen-bio.com

Founders:

Number of Employees:

101-250

Last Funding Date:

2023-11-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai